A marriage of formal methods and LLMs seeks to harness the strengths of both.
Hi, everyone, and welcome. I'm Najat Khan, Recursion's Chief R&D and Chief Commercial Officer and incoming CEO and President. Let's jump right in. Today is an important moment for Recursion, for our ...
Abstract: This study addresses the challenge of precise control of the maglev system under the condition of rapid time-varying dynamics and large time delay. Maglev technology has been applied in many ...
Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. MIT and Recursion have released Boltz-2, the first ...
PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a leading ...
The pharmaceutical industry is on the cusp of an AI-driven revolution. By 2030, AI-powered drug discovery is projected to be a $9.1 billion market, growing at a staggering 29.7% CAGR. AI promises to ...
Introduction: The excessive uncertainty of in modern manufacturing systems is caused by machine failures, changes in material information, and other factors. In addition, the organizational production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results